Oncology
5,770 studies495 in 7 days2,675 in 30 days
Filters
Latest
5,770 studies
- Chromosomal mutational signatures of DNA damaging agents at single cell resolution
- A patient-centric therapeutic paradigm uncouples prostate cancer suppression from systemic metabolic collapse
- Antibody co-administration robustly improves proton therapy with radiosensitizing nanoparticles: a mathematical modeling study
- Dissecting the TMEM132A-EGFR Dependency to Unlock Translational Therapeutic Opportunities for Pan-Solid Tumor
- Pretrained transformers applied to population cancer registries improve survival prediction in label-scarce and previously unseen cancers
- Pan-cancer analysis identifies nine conserved miRNA regulators of tumor cytolytic activity and clinically actionable immune targets
- ZNF217-USP15 signaling loop regulates oncogenic phenotypes in ovarian cancer cells
- Distal-less homeobox 5 gives rise to myofibroblastic carcinoma-associated fibroblasts to promote collective breast cancer invasion
- Complement receptor C3aR marks heterogeneous tumor‐associated macrophage states associated with improved survival in IDH ‐wildtype glioblastoma
- Targeting Metabolic Reprogramming in Cancer: Past, Present, and Future
- Adoption and outcomes of robotic pancreatectomy in the United States: An instrumental variable analysis.
- Glioblastoma Tumors with Decelerated Epigenetic Aging Are Characterized by Glutamatergic Neuronal Activity and Stemness
- Targeting the FBXL12-FANCD2 Pathway Disrupts Replication Stress Tolerance in MYCN-Driven Neuroblastoma
- Tumor-adjacent B cell infiltration stratifies recurrence risk in localized prostate cancer
- LLM-assisted evidence audit of late-stage cancer incidence as a screening trial endpoint
- Real-World Use of Adjuvant Nivolumab for Resected Stage III–IV Melanoma: 2-Year Analysis of AdjuMel
- Molecular profiling and disease tracking of posttransplant lymphoproliferative disorders using cell-free DNA∗
- InflaMix Predicts Severe CRS, ICU Admission, and Progression‐Free Survival After CAR‐T Therapy in LBCL
- Extended Follow-up of Botensilimab plus Balstilimab in an Expanded Cohort of Microsatellite-Stable Metastatic Colorectal Cancer without Active Liver Metastases
- Treatment-dependent and independent prognostic value of inflammation-based nutritional indices in immune checkpoint inhibitor-based therapy for esophageal cancer
- Osteocalcin and C-terminal telopeptide of type I collagen in serum and saliva: A cross-sectional pilot study on correlations and implications for MRONJ risk stratification in women on antiresorptive medications.
- Plasma proteomic profiles associated with low-dose computed tomography findings and incident lung cancer: a prospective pilot study
- Synergistic effects and molecular mechanisms of pirfenidone combined with EGFR-TKIs in non-small cell lung cancer
- Impact of different TP53 mutation subtypes on response and outcome in advanced lung adenocarcinoma receiving first-line immunotherapy or chemo-immunotherapy
- Survivin Promotes the Formation of a Microtubule-Based Glycolytic Hub